Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects

A Single Centre, Randomised, Double-blind, Three-period Cross-over Trial to Investigate the 24-hour Pharmacokinetics After Single Dose of Insulin Detemir in Healthy Chinese Male Subjects

This trial is conducted in Asia. The aim of this trial is to investigate the pharmacokinetics after a single dose of insulin detemir in healthy Chinese male subjects.

Inclusion Criteria:

• Body mass index (BMI) between 18 and 25 kg/m^2 (both inclusive)
• Fasting plasma glucose maximum 6 mmol/L
• Non-smoker
• Considered generally healthy upon completion of medical history, physical examination and laboratory assessments, as judged by the Investigator

Exclusion Criteria:

• Known or suspected allergy to trial product(s) or related products
• Previous participation in this trial. Participation is defined as randomisation
• Receipt of any investigational drug within the last three months prior to this trial
• History of alcohol or drug abuse